Pulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) P/B ratio
As of 5 November 2026, Pulse Biosciences, Inc (PLSE) trades at a P/B ratio of 20.8×. Over the past ten years it has ranged from 0.0× (June 2023) to 46.3× (August 2024); the current reading is higher than 89% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 11.5× | — |
| FY2022 | 0.0× | — |
| FY2021 | 11.6× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 19.6× | 1.42% |
| Jun 2026 | 19.3× | (12.90%) |
| Mar 2026 | 22.1× | 93.00% |
| Dec 2025 | 11.5× | (10.84%) |
| 6 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NVST Envista Holdings Corporation compare | 1.3× |
| MMED MiniMed Group, Inc. compare | 1.4× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATRC AtriCure, Inc. compare | 5.6× |
| WRBY Warby Parker Inc. compare | 8.1× |
| PLSE Pulse Biosciences, Inc | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement